2-[4(3)-Amino-3(4)-hydroxyphenylimino]-imidazolines, useful in the treatment of gastric hypersecretion and hyperacidity
US4492709A · kind A · utility
Assignee
Inventor
Key dates
| Filing date | Jan 25, 1983 |
| Grant date | Jan 8, 1985 |
| Priority date | — |
| Expiry date | Jan 25, 2003 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Imidazolidine derivatives of the formula: ##STR1## wherein R.sub.1 represents the hydroxy radical and R.sub.2 represents a grouping --NHSO.sub.2 CH.sub.3, --NHCOR' or --NHCONR'R", R' and R" independently of one another representing a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms, or alternatively R.sub.2 represents the hydroxy radical and R.sub.1 represents a grouping --NHSO.sub.2 CH.sub.3, --NHCOR' or ?NHCONR'R", R' and R" independently of one another representing a hydrogen atom or an alkyl radical having from 1 to 4 carbon atoms, and pharmacologically-acceptable acid addition salts thereof, are new therapeutically useful compounds. They are more particularly useful in the treatment of gastric hypersecretion or hyperacidity or glaucoma.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.